Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aplagon Oy

Clinical trials sponsored by Aplagon Oy, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug APAC aims to prevent blood clots in leg artery patients Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug APAC aims to prevent blood clots in leg artery patients

Disease control Recruiting now

This study tests a new drug called APAC, which is designed to prevent blood clots in people with blocked leg arteries. The trial includes 42 adults with peripheral arterial disease or chronic limb-threatening ischemia. Researchers will check if APAC is safe and well-tolerated, an…

Phase 2 • Sponsor: Aplagon Oy • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC